MetaADEDB 2.0 @ LMMD
Ritanserin
(JUQLTPCYUFPYKE-UHFFFAOYSA-N)
Structure
SMILES
Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
Type(s)
Investigational
Molecular Formula:
C27H25F2N3OS
Molecular Weight:
477.569
Log P:
5.4209
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
0
TPSA:
65.85
CAS Number(s):
87051-43-2
Synonym(s)
1.
Ritanserin
2.
6-(2-(4-(Bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-5H-thiazolo(3,2-a)pyrimidin-5-one
3.
R-55667
4.
Ritanserin Hydrochloride
5.
Ritanserin Tartrate
6.
R 55667
7.
R55667
External Link(s)
MeSHD016713
PubChem Compound5074
BindingDB50001775
ChEBI64195
CHEMBLCHEMBL267777
DrugBankDB12693
IUPHAR/BPS Guide to PHARMACOLOGY97
KEGGdr:D05738
Therapeutic Target DatabaseD0N2OM
D0K8NW
ZINC538314
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Amnesia16364460CTD
2Catalepsy9181636
12970091
16047547		CTD
3Craniofacial Abnormalities10978843
14991402		CTD
4Dyskinesia, Drug-Induced10371652
11779040
16511872		CTD
5Edema15748628CTD
6Fever11642332CTD
7Tremor10762688CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.